Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gretchen Tamms"'
Autor:
Timothy J Chapman, Liset Olarte, Ghassan Dbaibo, Avril Melissa Houston, Gretchen Tamms, Robert Lupinacci, Kristen Feemster, Ulrike K Buchwald, Natalie Banniettis
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 137-147 (2024)
ABSTRACTIntroduction Streptococcus pneumoniae is a causative agent of pneumonia and acute otitis media (AOM), as well as invasive diseases such as meningitis and bacteremia. PCV15 (V114) is a new 15-valent pneumococcal conjugate vaccine (PCV) approve
Externí odkaz:
https://doaj.org/article/8a4c9057ccf6425a95168278db4e417f
Autor:
Laura L. Hammitt, Dean Quinn, Ewa Janczewska, Francisco J. Pasquel, Richard Tytus, K. Rajender Reddy, Katia Abarca, Ilsiyar M. Khaertynova, Ron Dagan, Rachel Dawson, Jennifer McCauley, Tulin Shekar, Wei Fu, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Immunocompetent adults with certain medical and behavioral factors are at increased risk of pneumococcal disease. In some countries, sequential vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polys
Externí odkaz:
https://doaj.org/article/f875d2655e614b2e8e50c8bd1322293d
Autor:
Charles T. Quinn, Richard T. Wiedmann, Daniel Jarovsky, Eduardo Lopez-Medina, Hilze M. Rodriguez, Melanie Papa, Gordana Boggio, Qiong Shou, Ron Dagan, Peter Richmond, Kristen Feemster, Richard McFetridge, Gretchen Tamms, Robert Lupinacci, Luwy Musey, Kara Bickham
Publikováno v:
Blood Advances. 7:414-421
Sickle cell disease (SCD) is an inherited red blood cell disease that results in a multitude of medical complications, including an increased risk of invasive disease caused by encapsulated bacteria, such as Streptococcus pneumoniae. Pneumococcal vac
Autor:
Heather, Platt, Tosin, Omole, Jose, Cardona, Neil J, Fraser, Richard A, Mularski, Charles, Andrews, Nizar, Daboul, Nancy, Gallagher, Aditi, Sapre, Jianing, Li, Adam, Polis, Doreen, Fernsler, Gretchen, Tamms, Weifeng, Xu, Rocio, Murphy, Julie, Skinner, Joseph, Joyce, Luwy, Musey
Publikováno v:
The Lancet Infectious Diseases. 23:233-246
A pneumococcal conjugate vaccine (PCV) specifically focused on serotypes associated with adult residual disease burden is urgently needed. We aimed to assess V116, an investigational 21-valent PCV, that contains pneumococcal polysaccharides (PnPs), w
Autor:
Jakub K. Simon, Nina Breinholt Staerke, Maria Hemming-Harlo, Stacey Layle, Ron Dagan, Tulin Shekar, Alison Pedley, Patricia Jumes, Gretchen Tamms, Tina Sterling, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Simon, J K, Staerke, N B, Hemming-Harlo, M, Layle, S, Dagan, R, Shekar, T, Pedley, A, Jumes, P, Tamms, G, Sterling, T, Musey, L, Buchwald, U K & for the V114-020 PNEU-TRUE study group 2022, ' Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years : A randomized phase 3 trial (PNEU-TRUE) ', Vaccine, vol. 40, no. 9, pp. 1342-1351 . https://doi.org/10.1016/j.vaccine.2021.12.067
Background: Older adults are at risk of pneumococcal disease and associated morbidity and mortality. This phase 3 study (V114-020) assessed lot-to-lot consistency across safety and immunogenicity outcomes for V114, a 15-valent pneumococcal conjugate
Autor:
Heather Platt, Doreen Fernsler, Nancy Gallagher, Aditi Sapre, Adam Polis, Lori Hall, Gretchen Tamms, Howard Schwartz, Julie Skinner, Joseph Joyce, Rocio Murphy, Luwy Musey
Publikováno v:
JAC-Antimicrobial Resistance. 5
Background V116, an investigational 21-valent PCV, contains the following pneumococcal polysaccharides (PnPs): 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 16F, 17F, 19A, 20, 22F, 23A, 23B, 24F, 31, 33F, 35B, and a de-O-acetylated 15B (deOAc15B). This phase
Autor:
Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, Wanatpreeya Phongsamart, Punnee Pitisuttithum, Mika Rämet, Peter Richmond, Yaru Shi, Ron Dagan, Lori Good, Melanie Papa, Robert Lupinacci, Richard McFetridge, Gretchen Tamms, Clay Churchill, Luwy Musey, Kara Bickham
Publikováno v:
Vaccine. 40(44)
Background: Despite widespread use of pneumococcal conjugate vaccines (PCVs) in children, morbidity and mortality caused by pneumococcal disease (PD) remain high. In addition, many children do not complete their PCV course on schedule. V114 is a 15-v
Autor:
Robert Lupinacci, Richard Rupp, Orasri Wittawatmongkol, Jake Jones, Jeffrey Quinones, Betul Ulukol, Ron Dagan, Peter Richmond, Jon E. Stek, Lizbeth Romero, Sandra Koseoglu, Gretchen Tamms, Richard McFetridge, Jianing Li, Kyeongmi Cheon, Luwy Musey, Natalie Banniettis, Kara Bickham
Publikováno v:
Vaccine.
Pneumococcal disease (PD) remains a major health concern with considerable morbidity and mortality in children. Currently licensed pneumococcal conjugate vaccines (PCVs) confer protection against PD caused by most vaccine serotypes, but non-vaccine s
Autor:
Androniki Bili, Scott Dobson, Jeffrey Quinones, Wanatpreeya Phongsamart, Peninnah Oberdorfer, Pope Kosalaraksa, Ron Dagan, Peter Richmond, Marissa Wilck, Waldimir Vallejos, Christine Nunn, Richard McFetridge, Gretchen Tamms, Rong Fu, Robert Lupinacci, Luwy Musey, Natalie Banniettis, Kara Bickham
Publikováno v:
Vaccine. 41(3)
Pneumococcal disease (PD) remains a major health concern globally. In children, pneumococcal conjugate vaccines (PCVs) provide protection against PD from most vaccine serotypes, but non-vaccine serotypes contribute to residual disease. V114 is a 15-v
Autor:
Laura L Hammitt, Dean Quinn, Ewa Janczewska, Francisco J Pasquel, Richard Tytus, K Rajender Reddy, Katia Abarca, Ilsiyar M Khaertynova, Ron Dagan, Jennifer McCauley, Kyeongmi Cheon, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey, Ulrike K Buchwald
Publikováno v:
Open forum infectious diseases. 9(3)
Background Adults with certain medical and behavioral factors are at increased risk for pneumococcal disease (PD). Sequential vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine